<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 10-year, retrospective review of the etiology, outcome, and complications of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in children from a nonurban population was conducted </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty-seven children were identified (14 boys, 13 girls), ages 1.25 to 17 years (mean 7.7 years) </plain></SENT>
<SENT sid="2" pm="."><plain>Etiologies included undetermined (22%), <z:hpo ids='HP_0005294'>arterial dissection</z:hpo> (19%), <z:hpo ids='HP_0003256'>coagulopathy</z:hpo> (15%), embolism (15%), <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> (11%), <z:e sem="disease" ids="C0002895" disease_type="Disease or Syndrome" abbrv="">sickle cell disease</z:e> (11%), isolated <z:mp ids='MP_0001864'>angiitis</z:mp> of the central <z:mp ids='MP_0008912'>nervous</z:mp> system or <z:hpo ids='HP_0002633'>vasculitis</z:hpo> (11%), or other known source (11%; two fibromuscular <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, one L-asparaginase) </plain></SENT>
<SENT sid="3" pm="."><plain>More than one risk factor was present in five children </plain></SENT>
<SENT sid="4" pm="."><plain>Seventeen (65%) children were anticoagulated, with no adverse events occurring </plain></SENT>
<SENT sid="5" pm="."><plain>Nine children were anticoagulated initially with low-molecular-weight <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Other treatments included <z:chebi fb="0" ids="50858">corticosteroids</z:chebi>; physical, occupational, and <z:e sem="disease" ids="C0009460,C0699719,C0037831" disease_type="Mental or Behavioral Dysfunction;Therapeutic or Preventive Procedure;Finding" abbrv="">speech therapy</z:e>; and <z:chebi fb="0" ids="35623">anticonvulsants</z:chebi> for concomitant <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Follow-up ranged from 3 to 60 months (mean 17 months) and was as follows: 6 (22%) were <z:mpath ids='MPATH_458'>normal</z:mpath>, 9 (33%) had mild impairment, and 12 (44%) had moderate to severe deficits </plain></SENT>
<SENT sid="8" pm="."><plain>There were no <z:hpo ids='HP_0011420'>deaths</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Neurologic complications included <z:hpo ids='HP_0001250'>seizure</z:hpo> (two), <z:hpo ids='HP_0000708'>behavioral problems</z:hpo> (two), and hemorrhagic conversion (one) </plain></SENT>
<SENT sid="10" pm="."><plain>In this population, the outcome from <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> was similar to that of other studies, with the majority of children demonstrating persistent neurologic deficits </plain></SENT>
<SENT sid="11" pm="."><plain>Etiology could be determined for the majority of patients, with 19% having more than one risk factor </plain></SENT>
</text></document>